Astrazeneca (AZN) Income from Continuing Operations (2009 - 2026)
Astrazeneca's Income from Continuing Operations came in at $3.09 billion for Q2 2026, down 18.8% from $3.81 billion a year earlier and down 34.9% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Astrazeneca reported Income from Continuing Operations of $25.89 billion, up 120.5% year-over-year; for FY2025, it was $14.57 billion, up 40.9% from FY2024.
- Income from Continuing Operations has increased in each of the last three years, with a five-year compound annual growth rate of 25.5% (FY2020 to FY2025).
- Going back by year, Income from Continuing Operations was $10.34 billion in FY2024 (+30.9%), $7.9 billion in FY2023 (+362.2%), $1.71 billion in FY2022 and -$645 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Income from Continuing Operations since Q4 2024.
- Year-over-year, Income from Continuing Operations increased in seven of the last eight quarters, with growth averaging 116.5%.
- The fastest year-over-year change in Income from Continuing Operations over five years came in Q3 2023 (growth of 853.5%), and the weakest in Q2 2022 (a decline of 86.3%).
- Business Quant data shows AZN's Income from Continuing Operations at $4.75 billion (Q1 2026), $14.1 billion (Q4 2025) and $3.95 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 5.28 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 3.09 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.09 Bn |
| Mar 31, 2026 | 4.75 Bn |
| Dec 31, 2025 | 14.10 Bn |
| Sep 30, 2025 | 3.95 Bn |
| Jun 30, 2025 | 3.81 Bn |
| Mar 31, 2025 | 3.88 Bn |
| Dec 31, 2024 | 1.83 Bn |
| Sep 30, 2024 | 2.22 Bn |
| Jun 30, 2024 | 2.87 Bn |
| Mar 31, 2024 | 3.42 Bn |
| Dec 31, 2023 | 835.00 Mn |
| Sep 30, 2023 | 1.93 Bn |
| Jun 30, 2023 | 2.36 Bn |
| Mar 31, 2023 | 2.72 Bn |
| Dec 31, 2022 | 654.00 Mn |
| Sep 30, 2022 | 202.00 Mn |
| Jun 30, 2022 | 134.00 Mn |
| Mar 31, 2022 | 718.00 Mn |
| Dec 31, 2021 | -926.00 Mn |
| Sep 30, 2021 | -2.35 Bn |
API Access
Astrazeneca Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();